MedTrace Logo

Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant

NCT00898118 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2013-08-12

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is looking at blood samples in young patients with cytopenia after undergoing a donor stem cell transplant.

Conditions

Interventions

GENETIC

polymerase chain reaction

OTHER

flow cytometry

OTHER

laboratory biomarker analysis

PROCEDURE

allogeneic hematopoietic stem cell transplantation

Sponsors & Collaborators

  • European Working Group of MDS in Childhood

    lead OTHER

Principal Investigators

  • Peter Bader, MD · European Working Group of MDS in Childhood

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2013-03-31

Countries

  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Germany
  • Italy
  • Netherlands
  • Poland
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00898118 on ClinicalTrials.gov